Icon,

There doesn't seem to be any leaks of information on any direction RVX is taking,

We seem to be trading at the exercise price of the warrant extention program which indicates to me there were a few takers over the past few months to help with the day to day finances while RVX does what negotiations are going on behind the scenes,  The BTD was huge increase in valuation to RVX enterprise value that for some reason the market has either ignored or do not know.  We could get a development type of deal with a BP with a large upfront payment and a large backend deal if the Apabetalone gets an NDA after a bolt on trial, or maybe management has had to tamper their huge buyout expectations and except a discounted buyout , Either way we will found out sooner than later and then the market will wakeup IMO, 

I wouldn't say BP has walked away, They have far more money for a less potential small molecule drug just loom at the 47 take out for $4.9 Billion

We have way more potential for future sales and may get bought out for less money